MedTrace Logo

Evaluation of the Venous Excess Ultrasound Score (VExUS) After Circulating Volume Modification in Children.

NCT06695546 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 67

Last updated 2026-01-14

No results posted yet for this study

Summary

Venous overload has an impact on peripheral organ perfusion and on the short- and long-term prognosis of intensive care patients. The VExUS ultrasound score is a new tool whose parameters can be used to estimate this impact. This score was initially evaluated and validated on an adult population. ) In children, there is only one study looking at the use and applicability of this VExUS score, highlighting its feasibility in a paediatric population, as well as a possible correlation between elevated central venous pressure and altered renal Doppler (one of the score's components).

Conditions

  • Blood Volume Expansion

Interventions

OTHER

VExUS evaluation ultrasound

VExUS evaluation by ultrasound will be performed before the filling/bleeding/cleaning procedure, and again after the procedure: * Inferior vena cava measurement in Time-Motion (TM) mode, 1-2 cm from the right atrial orifice. * Hepatic venous Doppler measurement in pulsed Doppler mode. * Renal vein Doppler measurement in pulsed Doppler mode. Each measurement is performed three times consecutively (to average the results), then the ultrasound measurements are compiled into a score according to the degree of doppler severity.

Sponsors & Collaborators

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • Montserrat SIERRA COLOMINA, MD · University Hospital, Toulouse

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-10
Primary Completion
2025-06-06
Completion
2025-06-06

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06695546 on ClinicalTrials.gov